Artificial Intelligence for COVID-19: A Systematic Review

Lian Wang, Yonggang Zhang*, Dongguang Wang, Xiang Tong, Tao Liu, Shijie Zhang, Jizhen Huang, Li Zhang, Lingmin Chen, Hong Fan*, Mike Clarke*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

31 Downloads (Pure)

Abstract

Background: Recently, Coronavirus Disease 2019 (COVID-19), caused by severe acute respiratory syndrome virus 2 (SARS-CoV-2), has affected more than 200 countries and lead to enormous losses. This study systematically reviews the application of Artificial Intelligence (AI) techniques in COVID-19, especially for diagnosis, estimation of epidemic trends, prognosis, and exploration of effective and safe drugs and vaccines; and discusses the potential limitations.

Methods: We report this systematic review following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. We searched PubMed, Embase and the Cochrane Library from inception to 19 September 2020 for published studies of AI applications in COVID-19. We used PROBAST (prediction model risk of bias assessment tool) to assess the quality of literature related to the diagnosis and prognosis of COVID-19. We registered the protocol (PROSPERO CRD42020211555).

Results: We included 78 studies: 46 articles discussed AI-assisted diagnosis for COVID-19 with total accuracy of 70.00 to 99.92%, sensitivity of 73.00 to 100.00%, specificity of 25 to 100.00%, and area under the curve of 0.732 to 1.000. Fourteen articles evaluated prognosis based on clinical characteristics at hospital admission, such as clinical, laboratory and radiological characteristics, reaching accuracy of 74.4 to 95.20%, sensitivity of 72.8 to 98.00%, specificity of 55 to 96.87% and AUC of 0.66 to 0.997 in predicting critical COVID-19. Nine articles used AI models to predict the epidemic of the COVID-19, such as epidemic peak, infection rate, number of infected cases, transmission laws, and development trend. Eight articles used AI to explore potential effective drugs, primarily through drug repurposing and drug development. Finally, 1 article predicted vaccine targets that have the potential to develop COVID-19 vaccines.

Conclusions: In this review, we have shown that AI achieved high performance in diagnosis, prognosis evaluation, epidemic prediction and drug discovery for COVID-19. AI has the potential to enhance significantly existing medical and healthcare system efficiency during the COVID-19 pandemic.
Original languageEnglish
Article number704256
JournalFrontiers in Medicine
Volume8
Early online date30 Sep 2021
DOIs
Publication statusEarly online date - 30 Sep 2021

Keywords

  • Medicine
  • artificial intelligence
  • COVID-19
  • diagnosis
  • prognosis evaluation
  • epidemic prediction
  • drug discovery 2

Fingerprint

Dive into the research topics of 'Artificial Intelligence for COVID-19: A Systematic Review'. Together they form a unique fingerprint.

Cite this